Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
3(11%)
Results Posted
0%(0 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_4
1
4%
Ph phase_2
2
7%
Ph not_applicable
9
32%
Ph phase_1
1
4%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
2(15.4%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
9(69.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

3

trials recruiting

Total Trials

28

all time

Status Distribution
Active(5)
Completed(8)
Terminated(2)
Other(13)

Detailed Status

unknown13
Completed8
Recruiting3
Not yet recruiting2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
28
Active
3
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.7%)
Phase 22 (15.4%)
Phase 41 (7.7%)
N/A9 (69.2%)

Trials by Status

not_yet_recruiting27%
unknown1346%
completed829%
terminated14%
withdrawn14%
recruiting311%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT07425067

Upper Gastrointestinal Endoscopy in HIV-infected Individuals

Recruiting
NCT07315893Not Applicable

Endoscopic Full Thickness Suturing of Mucosal, Submucosal and Perforation Defects Using Su2ura® GI System

Recruiting
NCT06877507

Rapid Diagnostic Technology for AUGIB Based on Analysis of VOCs in Exhaled Breath

Not Yet Recruiting
NCT03420729Not Applicable

Acceptability and Tolerability of Magnetic Assisted Capsule Endoscopy Compared to Gastroscopy

Completed
NCT06143410Not Applicable

Intravenous Lidocaine to Reduce ED50 for Propofol Administered Using Target Controlled Infusion (TCI) During Gastroscopy

Unknown
NCT06363682

Interventional Reference Levels (IRL) in Digestive Endoscopy

Not Yet Recruiting
NCT05944887Not Applicable

Intravenous Lidocaine to Reduce Propofol Consumption During Gastroscopy.

Completed
NCT05956847

The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric

Recruiting
NCT05829486

Integrated Pulmonary Index in Gastroscopic Procedures

Unknown
NCT05326971Phase 4

The Effect Tenofovir Disoproxil Fumarate (TDF) and Tenofovir Alafenamide (TAF) on Small Intestine Gut Wall

Unknown
NCT05773807Not Applicable

Effect of Bispectral Index Monitoring (BIS) on Body Movement of Outpatients Undergoing Gastroscopy

Completed
NCT03410849Not Applicable

Long-term Adverse Effects After Bariatric Surgery on Oesophagus Epithelium

Completed
NCT04478929

Early Detection of Barrett's Esophagus Through Deep Image Retrieval

Unknown
NCT02219295Not Applicable

SEGATROM: Sensory and Gastrointestinal Impact of Taste Receptor Variants on Human Metabolism and Nutrition

Completed
NCT04434872Phase 2

Fecal Microbiota Transplantation as a Treatment for Ulcerative Colitis

Terminated
NCT04365946

Microbiome Analysis in Gastric Intestinal Metaplasia and in Gastric Cancer and Subtypes Correlation

Unknown
NCT02528461

Macrophage Activation Markers During Sofosbuvir-based Treatment Regimes of Chronic Hepatitis C

Completed
NCT03989973

Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis

Unknown
NCT03524144Not Applicable

Upper Gastrointestinal Lesions in Crohn's Disease

Unknown
NCT02114411

Gastropanel for Gastric Atrophy and Cancer Risk Assessment

Unknown

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
28